BridgeBio Pharma, Inc. (BBIO) Shareholders & Insider Trades
BridgeBio Pharma shareholders at a glance
The largest holder of BridgeBio Pharma stock is Janus Henderson Investors US LLC, with 14.1 million shares (7.22% of the company), worth about $1.08 billion as of September 25, 2026. The 10 largest holders together own 45.8%.
In Q2 2026, 518 institutional holdings reports listed shares worth $14.80 billion.
Insiders reported 87 transactions in the last two years: 52 sales worth $515.11 million and no purchases. The newest one on file is from May 8, 2026 (Kumar Neil, Chief Executive Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 8, 2026.
BridgeBio Pharma, Inc.
Shareholders Summary
2026Q2
Ownership by Type
Geographic Distribution
Largest BridgeBio Pharma shareholders
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Janus Henderson Investors US LLC | 14.1 million | 7.22% | $1.1B |
| Farallon Capital Management LLC | 10.7 million | 5.50% | $823.0M |
| Viking Global Investors LP | 9.9 million | 5.09% | $762.0M |
| Viking Global Investors LP | 9.8 million | 5.01% | $750.0M |
| BlackRock Advisors LLC | 9.7 million | 4.98% | $746.0M |
| Kohlberg Kravis Roberts & Co. LP | 9.2 million | 4.72% | $707.0M |
| Vanguard Capital Management LLC | 7.9 million | 4.04% | $605.0M |
| Vanguard Portfolio Management LLC | 7.7 million | 3.92% | $586.0M |
| Wellington Trust Co., NA | 5.3 million | 2.72% | $407.0M |
| Neil Kumar2.587 % | 5.1 million | 2.59% | $387.0M |
As of September 25, 2026.
BridgeBio Pharma institutional holdings by quarter
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 518 | – | $14.8B |
| Q1 2026 | 500 | 195.0 million | $14.4B |
| Q4 2025 | 489 | 192.0 million | $14.5B |
| Q3 2025 | 432 | 185.0 million | $9.6B |
| Q2 2025 | 402 | 191.0 million | $8.3B |
| Q1 2025 | 352 | 187.0 million | $6.5B |
| Q4 2024 | 314 | 177.0 million | $4.9B |
| Q3 2024 | 291 | 174.0 million | $4.4B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
BridgeBio Pharma insider trades
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Kumar Neil | May 8, 2026 | Chief Executive Officer | Sale at price 66.65 - 69.09 per share. | $5.4M |
| Apuli Maricel | Apr 30, 2026 | Officer | Sale at price 71.58 per share. | $143,160 |
| Kumar Neil | Apr 10, 2026 | Chief Executive Officer | Sale at price 73.64 - 75.55 per share. | $6.0M |
| Trimarchi Thomas | Mar 18, 2026 | President | Stock Award(Grant) at price 0.00 per share. | – |
| Apuli Maricel | Mar 18, 2026 | Officer | Stock Award(Grant) at price 0.00 per share. | – |
| Kumar Neil | Mar 13, 2026 | Chief Executive Officer | Sale at price 68.36 - 70.15 per share. | $5.5M |
| Valantine Hannah A. | Mar 10, 2026 | Director | Conversion of Exercise of derivative security at price 27.36 per share. | $237,239 |
| Valantine Hannah A. | Mar 10, 2026 | Director | Sale at price 72.00 per share. | $624,312 |
| Ellis Andrea | Mar 4, 2026 | Director | Conversion of Exercise of derivative security at price 8.45 per share. | $548,582 |
| Ellis Andrea | Mar 4, 2026 | Director | Sale at price 64.87 per share. | $4.2M |
| Valantine Hannah A. | Feb 27, 2026 | Director | Conversion of Exercise of derivative security at price 48.45 per share. | $1.2M |
| Valantine Hannah A. | Feb 27, 2026 | Director | Sale at price 67.08 - 67.84 per share. | $1.7M |
Newest 12 of 87 insider transactions in the last two years.
Questions and answers
Who owns the most BridgeBio Pharma stock?
Janus Henderson Investors US LLC, with 7.22% of the company (as of September 25, 2026). Next: Farallon Capital Management LLC (5.50%) and Viking Global Investors LP (5.09%).
How many institutions own BridgeBio Pharma stock?
518 institutional holdings reports listed BridgeBio Pharma shares in Q2 2026 worth $14.80 billion.
Are BridgeBio Pharma insiders buying or selling the stock?
In the last two years insiders reported 52 sales and no purchases (87 transactions in all); the newest on file is from May 8, 2026.
